LifeStance Health Group, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.08 | -$0.08 | -$0.08 |
Q2 2024 | 3 | -$0.07 | -$0.06 | -$0.07 |
Q3 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q4 2024 | 2 | -$0.07 | -$0.03 | -$0.05 |
Q1 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q2 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q3 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q4 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q1 2026 | 1 | $0.01 | $0.02 | $0.02 |
Q2 2026 | 1 | $0.01 | $0.01 | $0.01 |
Q3 2026 | 1 | $0.01 | $0.01 | $0.01 |
Q4 2026 | 1 | $0.02 | $0.02 | $0.02 |
LifeStance Health Group, Inc. Earnings Date And Information
LifeStance Health Group, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.05. The company had revenue of 312.72 M for the quarter and had revenue of 1.06 B for the year. LifeStance Health Group, Inc. has generated $-1 earnings per share over the last year ($-0.51 diluted earnings per share) and currently has a price-to-earnings ratio of -29.67. LifeStance Health Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
LifeStance Health Group, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.07 | -$0.02 | 0.05 | $302.25 M | $312.72 M |
08/08/2024 | Q2 2024 | -$0.07 | -$0.06 | 0.01 | $305.85 M | $312.33 M |
05/09/2024 | Q1 2024 | -$0.09 | -$0.06 | 0.03 | $300.44 M | |
12/29/2023 | Q4 2023 | -$0.12 | $280.60 M | |||
11/08/2023 | Q3 2023 | -$0.07 | -$0.17 | -0.1 | $255.18 M | $262.90 M |
08/09/2023 | Q2 2023 | -$0.09 | -$0.13 | -0.04 | $255.19 M | $259.58 M |
05/10/2023 | Q1 2023 | -$0.11 | -$0.09 | 0.02 | $252.59 M | |
03/09/2023 | Q4 2022 | -$0.12 | $229.36 M | |||
11/09/2022 | Q3 2022 | -$0.11 | $219.16 M | $217.56 M | ||
08/10/2022 | Q2 2022 | -$0.19 | $212.24 M | $209.53 M | ||
05/11/2022 | Q1 2022 | -$0.18 | $203.10 M | |||
03/17/2022 | Q4 2021 | -$0.33 | $190.00 M | |||
11/10/2021 | Q3 2021 | -$0.35 | $171.31 M | $173.84 M | ||
08/11/2021 | Q2 2021 | -$0.22 | $155.99 M | $160.55 M | ||
03/31/2021 | Q1 2021 | -$0.02 | $143.13 M | |||
12/31/2020 | Q4 2020 | -$0.02 | $118.12 M | |||
09/30/2020 | Q3 2020 | -$0.01 | $101.98 M | |||
06/30/2020 | Q2 2020 | -$0.01 | $45.45 M | |||
03/31/2020 | Q1 2020 | $0.01 | $73.11 M |
LifeStance Health Group, Inc. Earnings: Frequently Asked Questions
-
When is LifeStance Health Group, Inc.'s earnings date?
LifeStance Health Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did LifeStance Health Group, Inc. beat their earnings estimates last quarter?
In the previous quarter, LifeStance Health Group, Inc. (:LFST) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.05.
-
How can I listen to LifeStance Health Group, Inc.'s earnings conference call?
The conference call for LifeStance Health Group, Inc.'s latest earnings report can be listened to online.
-
How can I read LifeStance Health Group, Inc.'s conference call transcript?
The conference call transcript for LifeStance Health Group, Inc.'s latest earnings report can be read online.
-
How much revenue does LifeStance Health Group, Inc. generate each year?
LifeStance Health Group, Inc. (:LFST) has a recorded annual revenue of $1.06 B.
-
How much profit does LifeStance Health Group, Inc. generate each year?
LifeStance Health Group, Inc. (:LFST) has a recorded net income of $1.06 B. LifeStance Health Group, Inc. has generated $-0.51 earnings per share over the last four quarters.
-
What is LifeStance Health Group, Inc.'s price-to-earnings ratio?
LifeStance Health Group, Inc. (:LFST) has a price-to-earnings ratio of -29.67 and price/earnings-to-growth ratio is -0.76.